BRCA1 and neoplasm: We could show that a BRCA1 promotor hypermethylation was identified in two tumor samples belonging to either group B or C. Together with the two samples with BRCA2 fusion genes in group A, this observation demonstrates that genomic mutation analysis at the DNA level alone may not detect all tumors with HRD.